Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
Thrombosis and Haemostasis|January 1, 1994
Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international studyG J Miller, Y Stirling, M P Esnouf, et al.
Annals of Hematology|October 24, 2000
IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study GroupM Feuring-Buske, M Kneba, M Unterhalt, et al.
Bone Marrow Transplantation|February 5, 2013
CD34(+) lineage specific donor cell chimerism for the diagnosis and treatment of impending relapse of AML or myelodysplastic syndrome after allo-SCTF Rosenow, A Berkemeier, U Krug, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphomaM Mohr, F Dalmis, E Hilgenfeld, et al.
Leukemia|July 3, 2002
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemiaT Padró, R Bieker, S Ruiz, et al.
Blood|November 23, 2000
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathwaysM Mizuki, R Fenski, H Halfter, et al.
Annals of Hematology|March 4, 2003
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemiaJ Schetelig, C Thiede, M Bornhäuser, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Bone Marrow Transplantation|June 11, 2003
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factorH G Sayer, M Kröger, J Beyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study GroupJ Schetelig, C Thiede, M Bornhauser, et al.
Pageof 12